Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
206650.KQ Stock Summary
Top 10 Correlated ETFs
206650.KQ
In the News
206650.KQ Financial details
Company Rating
Neutral
Market Cap
442.54B
Income
-13.88B
Revenue
69.37B
Book val./share
3055.1
Cash/share
308.73
Dividend
-
Dividend %
-
Employees
323
Optionable
No
Shortable
Yes
Earnings
09 Feb 2021
P/E
-89.44
Forward P/E
9.71
PEG
-0.77
P/S
6.51
P/B
3.15
P/C
39.26
P/FCF
31.29
Quick Ratio
0.41
Current Ratio
1.43
Debt / Equity
0.12
LT Debt / Equity
0.03
-
-
EPS (TTM)
-380.72
EPS next Y
1248
EPS next Q
-
EPS this Y
1161.31%
EPS next Y
-427.8%
EPS next 5Y
-427.8%
EPS last 5Y
63.74%
Revenue last 5Y
15.97%
Revenue Q/Q
135.23%
EPS Q/Q
309.67%
-
-
-
-
SMA20
2.75%
SMA50
16.25%
SMA100
28.13%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-3%
ROC
-0.03%
Gross Margin
42%
Oper. Margin
-8%
Profit Margin
-7%
Payout
-
Shs Outstand
36.45M
Shs Float
25.59M
-
-
-
-
Target Price
-
52W Range
6260.0-13500.0
52W High
-10.22%
52W Low
+93.61%
RSI
49
Rel Volume
0.41
Avg Volume
324.08K
Volume
134.3K
Perf Week
-0.08%
Perf Month
-1.86%
Perf Quarter
17.1%
Perf Half Y
17.21%
-
-
-
-
Beta
1.273
-
-
Volatility
287.97%, 350.04%
Prev Close
-0.08%
Price
12120
Change
-1.46%
206650.KQ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.21K | 1.02K | 1.11K | 1.52K | 1.9K | |
Net income per share | -32.35 | -2.15K | -777.82 | -30.19 | -380.79 | |
Operating cash flow per share | 472.55 | -32.61 | -214.44 | 176.92 | 725.75 | |
Free cash flow per share | -542.95 | -387.32 | -472.8 | -671.18 | -472.06 | |
Cash per share | 357.16 | 1.94K | 889.83 | 303.67 | 308.79 | |
Book value per share | 1.28K | 3.46K | 3.38K | 3.42K | 3.06K | |
Tangible book value per share | 1.18K | 3.4K | 3.26K | 3.21K | 2.85K | |
Share holders equity per share | 1.28K | 3.46K | 3.38K | 3.42K | 3.06K | |
Interest debt per share | 1.3K | 795.93 | 398.87 | 395.61 | 401.86 | |
Market cap | 215.3B | 596.79B | 1242.54B | 314.88B | 402.02B | |
Enterprise value | 246.98B | 566.27B | 1251.52B | 319.5B | 406.9B | |
P/E ratio | -244.2 | -9.92 | -45.06 | -286.55 | -28.97 | |
Price to sales ratio | 6.51 | 20.95 | 31.55 | 5.68 | 5.8 | |
POCF ratio | 16.72 | -653.27 | -163.45 | 48.89 | 15.2 | |
PFCF ratio | -14.55 | -54.99 | -74.13 | -12.89 | -23.37 | |
P/B Ratio | 6.16 | 6.16 | 10.35 | 2.53 | 3.61 | |
PTB ratio | 6.16 | 6.16 | 10.35 | 2.53 | 3.61 | |
EV to sales | 7.47 | 19.88 | 31.78 | 5.76 | 5.87 | |
Enterprise value over EBITDA | 19.33 | -42.92K | -1.88K | 77.67 | 24.12 | |
EV to operating cash flow | 19.18 | -619.86 | -164.63 | 49.61 | 15.38 | |
EV to free cash flow | -16.69 | -52.18 | -74.67 | -13.08 | -23.65 | |
Earnings yield | 0 | -0.1 | -0.02 | 0 | -0.03 | |
Free cash flow yield | -0.07 | -0.02 | -0.01 | -0.08 | -0.04 | |
Debt to equity | 1 | 0.21 | 0.11 | 0.11 | 0.12 | |
Debt to assets | 0.38 | 0.13 | 0.09 | 0.08 | 0.08 | |
Net debt to EBITDA | 2.48 | 2.31K | -13.5 | 1.12 | 0.29 | |
Current ratio | 0.78 | 2.03 | 3.11 | 2.31 | 1.83 | |
Interest coverage | 30.19 | -2.79 | -8.63 | -4.34 | 5.44 | |
Income quality | -14.61 | 0.02 | 0.28 | -5.86 | -1.91 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.03 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.12 | 0.28 | 0.4 | 0.27 | 0.25 | |
Intangibles to total assets | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -2.15 | 10.88 | 1.2 | -4.79 | -1.65 | |
Capex to revenue | -0.84 | -0.35 | -0.23 | -0.56 | -0.63 | |
Capex to depreciation | -9.32 | -1.67 | -1.4 | -3.92 | -4.76 | |
Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.05 | 0 | |
Graham number | 966.19 | 12.92K | 7.7K | 1.52K | 5.12K | |
ROIC | 0.19 | -0.05 | -0.05 | -0.03 | 0.06 | |
Return on tangible assets | -0.01 | -0.39 | -0.19 | -0.01 | -0.08 | |
Graham Net | -1.56K | 168.42 | 265.16 | -895.11 | -1.1K | |
Working capital | -5.99B | 36.21B | 36.44B | 34.34B | 21.61B | |
Tangible asset value | 32.04B | 95.35B | 115.52B | 116.9B | 103.93B | |
Net current asset value | -36.32B | 12.33B | 20.55B | 3.12B | -20.2B | |
Invested capital | 1 | 0.21 | 0.11 | 0.11 | 0.12 | |
Average receivables | 0 | 4.3B | 5.62B | 5.69B | 9.8B | |
Average payables | 0 | 247.34M | 253.55M | 582.16M | 745.94M | |
Average inventory | 0 | 8.46B | 12.01B | 16.39B | 15.68B | |
Days sales outstanding | 24.53 | 81.78 | 45 | 42.88 | 68.82 | |
Days payables outstanding | 7.54 | 3.25 | 4.48 | 9.4 | 6.32 | |
Days of inventory on hand | 195.45 | 150.99 | 214.63 | 197.77 | 132.66 | |
Receivables turnover | 14.88 | 4.46 | 8.11 | 8.51 | 5.3 | |
Payables turnover | 48.43 | 112.42 | 81.55 | 38.83 | 57.74 | |
Inventory turnover | 1.87 | 2.42 | 1.7 | 1.85 | 2.75 | |
ROE | -0.03 | -0.62 | -0.23 | -0.01 | -0.12 | |
Capex per share | -1.02K | -354.71 | -258.36 | -848.1 | -1.2K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 477.98 | 394.97 | 456.73 | 313.68 | 737.72 | |
Net income per share | -87.57 | -2.91 | 55.92 | -85.1 | -348.63 | |
Operating cash flow per share | 17.48 | -33.92 | 292.13 | 234.43 | 233.09 | |
Free cash flow per share | -237.18 | -130.87 | -357.84 | 13.99 | 2.63 | |
Cash per share | 303.31 | 188.46 | 207.32 | 234.59 | 308.73 | |
Book value per share | 3.42K | 3.44K | 3.47K | 3.4K | 3.06K | |
Tangible book value per share | 3.21K | 3.22K | 3.24K | 3.13K | 2.85K | |
Share holders equity per share | 3.42K | 3.44K | 3.47K | 3.4K | 3.06K | |
Interest debt per share | 377.78 | 378.08 | 382.17 | 375.51 | 375.82 | |
Market cap | 315.25B | 262.4B | 271.51B | 383.41B | 402.1B | |
Enterprise value | 319.87B | 270.95B | 279.77B | 390.27B | 406.98B | |
P/E ratio | -24.7 | -618.9 | 33.31 | -30.9 | -7.91 | |
Price to sales ratio | 18.1 | 18.23 | 16.31 | 33.54 | 14.95 | |
POCF ratio | 494.91 | -212.29 | 25.5 | 44.88 | 47.32 | |
PFCF ratio | -36.47 | -55.01 | -20.82 | 752.09 | 4.19K | |
P/B Ratio | 2.53 | 2.09 | 2.15 | 3.09 | 3.61 | |
PTB ratio | 2.53 | 2.09 | 2.15 | 3.09 | 3.61 | |
EV to sales | 18.36 | 18.82 | 16.81 | 34.14 | 15.13 | |
Enterprise value over EBITDA | -331.52 | 161.23 | 64.66 | -411.11 | 34.46 | |
EV to operating cash flow | 502.16 | -219.2 | 26.28 | 45.68 | 47.9 | |
EV to free cash flow | -37 | -56.81 | -21.45 | 765.55 | 4.25K | |
Earnings yield | -0.01 | 0 | 0.01 | -0.01 | -0.03 | |
Free cash flow yield | -0.03 | -0.02 | -0.05 | 0 | 0 | |
Debt to equity | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | |
Debt to assets | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | |
Net debt to EBITDA | -4.79 | 5.08 | 1.91 | -7.23 | 0.41 | |
Current ratio | 2.31 | 1.74 | 1.65 | 1.43 | 1.83 | |
Interest coverage | -13.09 | -1.86 | 5.21 | -10.7 | 20.25 | |
Income quality | -0.2 | 11.66 | 5.22 | -2.75 | -0.67 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.33 | 0.36 | 0.36 | 0.4 | 0.06 | |
Intangibles to total assets | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
Capex to operating cash flow | -14.57 | 2.86 | -2.22 | -0.94 | -0.99 | |
Capex to revenue | -0.53 | -0.25 | -1.42 | -0.7 | -0.31 | |
Capex to depreciation | -4.4 | -1.66 | -10.14 | -3.41 | -3.58 | |
Stock based compensation to revenue | 0.02 | 0.04 | -0.08 | 0.02 | 0 | |
Graham number | 2.59K | 474.44 | 2.09K | 2.55K | 4.9K | |
ROIC | -0.02 | 0 | 0.02 | -0.02 | 0.08 | |
Return on tangible assets | -0.02 | 0 | 0.01 | -0.02 | -0.07 | |
Graham Net | -894.05 | -474.65 | -573.63 | -718.24 | -1.1K | |
Working capital | 34.34B | 17.16B | 15.07B | 10.36B | 21.61B | |
Tangible asset value | 116.9B | 117.37B | 117.97B | 114.2B | 103.93B | |
Net current asset value | 3.12B | -1.69B | -7.63B | -12.22B | -20.2B | |
Invested capital | 0.11 | 0.11 | 0.11 | 0.11 | 0.12 | |
Average receivables | 5.84B | 9.45B | 12.8B | 9.15B | 9.08B | |
Average payables | 676.76M | 629.1M | 376.33M | 435.94M | 578.49M | |
Average inventory | 20.67B | 17.44B | 16.08B | 15.73B | 14.76B | |
Days sales outstanding | 33.67 | 77.38 | 71.54 | 39.94 | 43.77 | |
Days payables outstanding | 6.27 | 5.03 | 3.9 | 5.78 | 4.25 | |
Days of inventory on hand | 131.95 | 211.02 | 170.09 | 179.33 | 89.28 | |
Receivables turnover | 2.67 | 1.16 | 1.26 | 2.25 | 2.06 | |
Payables turnover | 14.35 | 17.9 | 23.08 | 15.57 | 21.16 | |
Inventory turnover | 0.68 | 0.43 | 0.53 | 0.5 | 1.01 | |
ROE | -0.03 | 0 | 0.02 | -0.03 | -0.11 | |
Capex per share | -254.66 | -96.96 | -649.97 | -220.44 | -230.46 |
206650.KQ Frequently Asked Questions
What is EuBiologics Co., Ltd. stock symbol ?
EuBiologics Co., Ltd. is a KR stock and trading under the symbol 206650.KQ
What is EuBiologics Co., Ltd. stock quote today ?
EuBiologics Co., Ltd. stock price is $12120 today.
Is EuBiologics Co., Ltd. stock public?
Yes, EuBiologics Co., Ltd. is a publicly traded company.